Carrier Screening Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Type (Expanded Carrier Screening v/s Targeted Cancer Screening), By Screening Type (Prenatal Carrier Testing v/s Preconception Carrier Screening), By Technology (Next Generation Sequencing, Polymerase Chain Reaction, Microarrays, Others), By Indication (Cystic Fibrosis, Down’s Syndrome, Thalassemia, Tay-Sachs Disease, Huntington’s Disease, Sickle Cell Anemia, Others), By End User (Hospitals & Clinics, Reference Laboratories, Others), By Company, and By Region

  • Industry : Healthcare
  • Pages : NA
  • Published Date : NA
Customization Enquiry

Buy Now

Summary

Report Description

The global carrier screening market is anticipated to observe impressive growth during the forecast period, 2023-2027. The major factors include increasing occurrences of genetic conditions, rising emphasis on early detection and prevention, and technological developments in the field of genomics is fueling the growth of the market. Genetic conditions are diseases caused due to mutations in the normal DNA sequence. Carrier screening is a kind of test which helps to know the risk of having a child with a genetic disorder. It determines whether a healthy person contains the recessive gene of genetic diseases such as sickle cell disease, cystic fibrosis, and others. The other factors supporting the market's growth are rising investments on research and developments activities by government, rise in numerous releases and approvals of new carrier screening tests, increasing birth rate across the globe, rising focus on personalized medicine, growing awareness of carrier screening among the population, increasing maternal age, availability of mass genetic testing programs, and the high incidence of chromosomal disorders.

Rising Prevalence of Genetic Diseases

The rising incidences of genetic disorders, and fetal chromosomal anomalies due to mutation in genes or chromosomes, is bolstering the growth of the market, globally. For instance, in the U.S., genetic diseases are the primary cause of newborn deaths, accounting for nearly 20% of annual infant mortality. Genetic diseases such as cystic fibrosis, Tay-Sachs disease, and sickle cell anemia, occurs due to inheritable genetic conditions present in parents which may get inherited by the offspring. According to the World Health Organization (WHO), in 2019, about 2 to 5% of infants had genetic diseases or chromosomal abnormalities. Owing to the increasing occurrences of disabilities in newborns, the surge in demand for prenatal testing is propelling the growth of the market.

Rising Emphasis on Early Detection and Prevention of Complex Genetic Disorders

In recent years, people have become more aware of the genetic disorders which enables them to plan and take better care of the baby. The growing inclination among urban parents to delay childbearing, and the higher average age of mothers lead to pregnancy complication, which is a contributing factor to facilitate the growth of the market. The early detection helps couples to know the risk of having child with genetic diseases or disorders in early stage of pregnancy. Thus, rising focus on early detection and prevention of complex genetic disorder is fueling the growth of the market, globally. Various initiatives are taken by government and non-government organization for early carrier screening. For instance, in 2018, “Step One Newborn Screening” was introduced by the Dubai health authority.

Technological Advancements fuels the Market Growth

Rise in adoption of advanced technology in the field of genomics sector is augmenting the growth of the market. The testing techniques are becoming more reliable and convenient because of technological advancements in the carrier screening methods. For instance, in 2022, Thermo Fisher Scientific Inc., American supplier of scientific products, announced the launch of NGS-based test kit, which is a type of carrier screening approach in single solution that assists to scan the genetic disorders, including gene expression.


Download Free Sample Report

Market Segmentation

The global carrier screening market is segmented into type, screening type, technology, indication, end user, and company. Based on type, the market is divided into expanded carrier screening and targeted cancer screening. Based on screening type, the market is divided into prenatal carrier testing and preconception carrier screening. Based on technology, the market is divided into next generation sequencing, polymerase chain reaction, microarrays, and others. Based on indication, the market is divided into cystic fibrosis, down’s syndrome, thalassemia, tay sachs disease, huntington’s disease, sickle cell anemia, and others. Based on end user, the market is divided into hospitals & clinics, reference laboratories, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to the increasing incidences of genetic conditions and technological advancements in the country.

Market Players

Eurofins Scientific, Inc., Fulgent Genetics, Inc., CENTOGENE N.V., Invitae Corporation, Illumina, Inc., Gene by Gene, Ltd., Laboratory Corporation of America Holdings, Natera, Inc., Myriad Genetics, Inc., and Quest Diagnostics, Inc are some of the leading companies operating in the market.

Attribute

Details

Base Year

2021

Historic Data

2017 – 2020

Estimated Year

2022

Forecast Period

2023 – 2027

Quantitative Units

Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments covered

·         Type

·         Screening Type

·         Technology

·         Indication

·         End User

·         Company

Regional scope

North America; Asia Pacific; Europe & CIS; South America; Middle East & Africa

Country scope

United States; Canada; Mexico; China; India; Japan; South Korea; Germany; France; United Kingdom; Spain; Italy; Brazil; Argentina; Colombia; South Africa; UAE; Saudi Arabia; South Africa;

Key companies profiled

Eurofins Scientific, Inc., Fulgent Genetics, Inc., CENTOGENE N.V., Invitae Corporation, Illumina, Inc., Gene by Gene, Ltd., Laboratory Corporation of America Holdings, Natera, Inc., Myriad Genetics, Inc., and Quest Diagnostics, Inc.

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


Report Scope:

In this report, global carrier screening market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

·         Carrier Screening Market, By Type:

    • Expanded Carrier Screening
    • Targeted Cancer Screening

·         Carrier Screening Market, By Screening Type:

    • Prenatal Carrier Testing
    • Preconception Carrier Screening

·         Carrier Screening Market, By Technology:

o    Next Generation Sequencing

o    Polymerase Chain Reaction

o    Microarrays

o    Others

·         Carrier Screening Market, By Indication:

    • Cystic Fibrosis
    • Down’s Syndrome
    • Thalassemia
    • Tay-Sachs Disease
    • Huntington’s Disease
    • Sickle Cell Anemia
    • Others

·         Carrier Screening Market, By End User:

    • Hospitals & Clinics
    • Reference Laboratories
    • Others  

·         Carrier Screening Market, By Region:

    • North America
      • United States
      • Canada
      • Mexico
    • Asia-Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
    • Europe & CIS
      • Germany
      • France
      • United Kingdom
      • Spain
      • Italy
    • South America
      • Brazil
      • Argentina
      • Colombia
    • Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

§  Turkey

§  Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Carrier Screening Market

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
Carrier Screening Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Product Overview

2.    Research Methodology

3.    Executive Summary

4.    Impact of COVID-19 on Global Carrier Screening Market

5.    Voice of Customer

6.    Global Carrier Screening Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Type (Expanded Carrier Screening v/s Targeted Cancer Screening)

6.2.2.     By Screening Type (Prenatal Carrier Testing v/s Preconception Carrier Screening)

6.2.3.     By Technology (Next Generation Sequencing, Polymerase Chain Reaction, Microarrays, Others)

6.2.4.     By Indication (Cystic Fibrosis, Down’s Syndrome, Thalassemia, Tay-Sachs Disease, Huntington’s Disease, Sickle Cell Anemia, Others)

6.2.5.     By End User (Hospitals & Clinics, Reference Laboratories, Others)

6.2.6.     By Region

6.2.7.     By Company (2021)

6.3.  Market Map

7.    North America Carrier Screening Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Type

7.2.2.     By Screening Type

7.2.3.     By Technology

7.2.4.     By Indication

7.2.5.     By End User

7.2.6.     By Country

7.3.  North America: Country Analysis

7.3.1.     United States Carrier Screening Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Type

7.3.1.2.2.             By Screening Type

7.3.1.2.3.             By Technology

7.3.1.2.4.             By Indication

7.3.1.2.5.             By End User

7.3.2.     Canada Carrier Screening Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Type

7.3.2.2.2.             By Screening Type

7.3.2.2.3.             By Technology

7.3.2.2.4.             By Indication

7.3.2.2.5.             By End User

7.3.3.     Mexico Carrier Screening Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Type

7.3.3.2.2.             By Screening Type

7.3.3.2.3.             By Technology

7.3.3.2.4.             By Indication

7.3.3.2.5.             By End User

8.    Europe Carrier Screening Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Type

8.2.2.     By Screening Type

8.2.3.     By Technology

8.2.4.     By Indication

8.2.5.     By End User

8.2.6.     By Country

8.3.  Europe: Country Analysis

8.3.1.     France Carrier Screening Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Type

8.3.1.2.2.             By Screening Type

8.3.1.2.3.             By Technology

8.3.1.2.4.             By Indication

8.3.1.2.5.             By End User

8.3.2.     Germany Carrier Screening Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Type

8.3.2.2.2.             By Screening Type

8.3.2.2.3.             By Technology

8.3.2.2.4.             By Indication

8.3.2.2.5.             By End User

8.3.3.     United Kingdom Carrier Screening Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Type

8.3.3.2.2.             By Screening Type

8.3.3.2.3.             By Technology

8.3.3.2.4.             By Indication

8.3.3.2.5.             By End User

8.3.4.     Italy Carrier Screening Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.             By Type

8.3.4.2.2.             By Screening Type

8.3.4.2.3.             By Technology

8.3.4.2.4.             By Indication

8.3.4.2.5.             By End User

8.3.5.     Spain Carrier Screening Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Type

8.3.5.2.2.             By Screening Type

8.3.5.2.3.             By Technology

8.3.5.2.4.             By Indication

8.3.5.2.5.             By End User

9.    Asia-Pacific Carrier Screening Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Type

9.2.2.     By Screening Type

9.2.3.     By Technology

9.2.4.     By Indication

9.2.5.     By End User

9.2.6.     By Country

9.3.  Asia-Pacific: Country Analysis

9.3.1.     China Carrier Screening Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Type

9.3.1.2.2.             By Screening Type

9.3.1.2.3.             By Technology

9.3.1.2.4.             By Indication

9.3.1.2.5.             By End User

9.3.2.     India Carrier Screening Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Type

9.3.2.2.2.             By Screening Type

9.3.2.2.3.             By Technology

9.3.2.2.4.             By Indication

9.3.2.2.5.             By End User

9.3.3.     Japan Carrier Screening Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Type

9.3.3.2.2.             By Screening Type

9.3.3.2.3.             By Technology

9.3.3.2.4.             By Indication

9.3.3.2.5.             By End User

9.3.4.     South Korea Carrier Screening Market Outlook

9.3.4.1.         Market Size & Forecast

9.3.4.1.1.             By Value

9.3.4.2.         Market Share & Forecast

9.3.4.2.1.             By Type

9.3.4.2.2.             By Screening Type

9.3.4.2.3.             By Technology

9.3.4.2.4.             By Indication

9.3.4.2.5.             By End User

9.3.5.     Australia Carrier Screening Market Outlook

9.3.5.1.         Market Size & Forecast

9.3.5.1.1.             By Value

9.3.5.2.         Market Share & Forecast

9.3.5.2.1.             By Type

9.3.5.2.2.             By Screening Type

9.3.5.2.3.             By Technology

9.3.5.2.4.             By Indication

9.3.5.2.5.             By End User

10.  South America Carrier Screening Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Type

10.2.2.  By Screening Type

10.2.3.  By Technology

10.2.4.  By Indication

10.2.5.  By End User

10.2.6.  By Country

10.3.              South America: Country Analysis

10.3.1.  Brazil Carrier Screening Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Type

10.3.1.2.2.           By Screening Type

10.3.1.2.3.           By Technology

10.3.1.2.4.           By Indication

10.3.1.2.5.           By End User

10.3.2.  Argentina Carrier Screening Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Type

10.3.2.2.2.           By Screening Type

10.3.2.2.3.           By Technology

10.3.2.2.4.           By Indication

10.3.2.2.5.           By End User

10.3.3.  Colombia Carrier Screening Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Type

10.3.3.2.2.           By Screening Type

10.3.3.2.3.           By Technology

10.3.3.2.4.           By Indication

10.3.3.2.5.           By End User

11.  Middle East and Africa Carrier Screening Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value

11.2.              Market Share & Forecast

11.2.1.  By Type

11.2.2.  By Screening Type

11.2.3.  By Technology

11.2.4.  By Indication

11.2.5.  By End User

11.2.6.  By Country

11.3.              MEA: Country Analysis

11.3.1.  South Africa Carrier Screening Market Outlook

11.3.1.1.      Market Size & Forecast

11.3.1.1.1.           By Value

11.3.1.2.      Market Share & Forecast

11.3.1.2.1.           By Type

11.3.1.2.2.           By Screening Type

11.3.1.2.3.           By Technology

11.3.1.2.4.           By Indication

11.3.1.2.5.           By End User

11.3.2.  Saudi Arabia Carrier Screening Market Outlook

11.3.2.1.      Market Size & Forecast

11.3.2.1.1.           By Value

11.3.2.2.      Market Share & Forecast

11.3.2.2.1.           By Type

11.3.2.2.2.           By Screening Type

11.3.2.2.3.           By Technology

11.3.2.2.4.           By Indication

11.3.2.2.5.           By End User

11.3.3.  UAE Carrier Screening Market Outlook

11.3.3.1.      Market Size & Forecast

11.3.3.1.1.           By Value

11.3.3.2.      Market Share & Forecast

11.3.3.2.1.           By Type

11.3.3.2.2.           By Screening Type

11.3.3.2.3.           By Technology

11.3.3.2.4.           By Indication

11.3.3.2.5.           By End User

12.  Market Dynamics

12.1.              Drivers

12.2.              Challenges

13.  Market Trends & Developments

14.  Competitive Landscape (Inclusive of SWOT Analysis)

Eurofins Scientific, Inc.

Fulgent Genetics, Inc.

CENTOGENE N.V.

Invitae Corporation

Illumina, Inc.

Gene by Gene, Ltd.

Laboratory Corporation of America Holdings

Natera, Inc.

Myriad Genetics, Inc.

Quest Diagnostics, Inc.

15.  Strategic Recommendations

Figures and Tables

Frequently asked questions

down-arrow

An increasing occurrence of genetic conditions, rising awareness among people regarding early detection and prevention, and technological developments in the field of genomics are driving the demand for the global carrier screening market.

down-arrow

Eurofins Scientific, Inc., Fulgent Genetics, Inc., CENTOGENE N.V., Invitae Corporation, Illumina, Inc., Gene by Gene, Ltd., Laboratory Corporation of America Holdings, Natera, Inc., Myriad Genetics, Inc., and Quest Diagnostics, Inc are the key players operating in the global carrier screening market.

down-arrow

The lack of high complexity testing centers, regulatory challenges in the field of carrier screening, and existing diagnostic confidence on conventional screening methods are likely to hamper the growth of global carrier screening market.

down-arrow

The Asia-Pacific is expected to register the highest CAGR during the forecast period.

Related Reports

profile

Sakshi Bajaal

Business Consultant
Press Release

Carrier Screening Market to be dominated by Rising Prevalence of Genetic Conditions through 2027

Sep, 2022

Growing prevalence of genetic diseases, and rising emphasis on early detection and prevention to drive the carrier screening market in the forecast period, 2023-2027.

Why Choose Us